It seems that patients with lung or colorectal cancer have poor enrollment in clinical trials, according to the recent multiregional survey carried out by the authors in a cohort of 8778 patients three to six months after diagnosis. Only 14% of patients have discussed their participation in clinical trials.
You are here:
Discussions About Clinical Trials Among Patients With Newly Diagnosed Lung and Colorectal Cancer
Submitted by: Marcelo Jimenez
Source: Journal of the National Cancer Institute
Keywords:
Author(s): Kenneth L. Kehl, Neeraj K. Arora, Deborah Schrag, John Z. Ayanian, Steven B. Clauser, Carrie N. Klabunde, Katherine L. Kahn, Robert H. Fletcher and Nancy L. Keating
Related Content
JANS Article
By: EACTS Staff
